Dr. Scott M. Schuetze, MD, PhD

  • Ann Arbor, MI
  • Medical oncologist
NPI1548346414PAC ID5092775932
Medicare services, 2024
209
Medicare patients, 2024
80
Part D claims, 2024
358
Publications
67
Clinical trials
11
Practice address
1500 E Medical Center Dr, Ann Arbor, MI 48109
Practice phone
Call (734) 936-4000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

University Hospital

School-Based Health Center · Ann Arbor, Michigan

See all 3 affiliations

Find Dr. Schuetze's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Scott M. Schuetze is a medical oncologist in Ann Arbor, Michigan

Dr. Schuetze practices at University Hospital in Ann Arbor, Michigan.

Dr. Schuetze's NPI, 1548346414, was assigned on October 31, 2006. Dr. Schuetze graduated from Oregon Health Sciences University School of Medicine in 1993. Dr. Schuetze holds Michigan license 4301084113.

NPI and contact details
Medicare PAC ID
5092775932
NPI enumeration date
October 31, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(734) 936-4000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
59
Medical school graduation
1993

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Scott M. Schuetze practices at University Hospital in Ann Arbor, Michigan

Dr. Schuetze's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

  • University Hospital
    1500 E Medical Center Dr, Ann Arbor, MI 48109Phone(734) 936-4000

Source: Dmand AI Affiliation Data

Dr. Scott M. Schuetze is affiliated with 2 sites of care and 1 medical group

Dr. Schuetze's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Schuetze is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dr. Schuetze's employer is on file too: a school & student health.

See all 3 affiliations for Dr. Schuetze

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Scott M. Schuetze's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schuetze practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
University HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Schuetze practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Scott M. Schuetze is one of 171 medical oncologists in Michigan

Medical oncology is Dr. Schuetze's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Schuetze is licensed in Michigan.

Specialties and state licenses

  • Medical oncology, MichiganPrimaryLicense 4301084113 · taxonomy 207RX0202X

Medical oncologists near Dr. Schuetze

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Scott M. Schuetze billed Medicare for 209 services in 2024

CMS data shows 209 Medicare services from Dr. Schuetze across 5 procedure codes in 2024, for 80 Medicare patients. Medicare paid $14,887 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024209
Medicare patients80
Paid by Medicare$14,887
Procedure codes5

Dr. Schuetze's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1622024: 1705%
Other services
2023: 02024: 39

Dr. Schuetze compared with the Michigan median for medical oncologists, 2024

  • Dr. Schuetze
  • Michigan median
Medicare services
209vs 36443% below
Medicare patients
80vs 13641% below
Part D claims
223vs 33433% below

Medians across 165 medical oncologists in Michigan with Dmand AI profiles that report each measure.

Dr. Schuetze's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Schuetze

Need commercial claims for Dr. Schuetze?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Schuetze and other medical oncologists in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Scott M. Schuetze treated 80 Medicare patients in 2024, average age 70

CMS counts 80 Medicare patients who saw Dr. Schuetze in 2024. The largest group is 65 to 74, with 35 patients. 71% of them have high blood pressure, and 61% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schuetze's median patient age at 63, with 53% women.

Medicare patients, 202480
Average age70
Average risk score2.41
Also on Medicaid20%

Dr. Schuetze's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Schuetze's Medicare patients by sex, 2024

  • Women3848%
  • Men4253%

Chronic conditions among Dr. Schuetze's Medicare patients, 2024

  1. High blood pressure71%
  2. High cholesterol61%
  3. Anxiety38%
  4. Arthritis36%
  5. Ischemic heart disease36%
  6. Mood disorders34%
  7. Cancer33%
  8. Chronic kidney disease31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Schuetze's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 63

Patient panel by sex, all payers

  • Women53%
  • Men47%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Scott M. Schuetze wrote 358 Medicare Part D claims in 2024

In 2024, Dr. Schuetze wrote 358 Medicare Part D claims for 74 patients. 86% of them were for generic drugs. CMS names the drug for 223 of them, across 7 drugs with 11 or more claims each, at $29,912 in total drug cost. In 2023, CMS named 216 claims across 6 drugs.

Part D claims, 2024358
Drugs named by CMS7
Total drug cost$29,912
Part D patients74

Dr. Schuetze's Part D claims by kind of drug, 2024

  • Generic309 claims86%
  • Brand-name49 claims14%

Dr. Schuetze's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Schuetze's Part D claims, 2024

  • Opioids9%32 of 358 claims
  • Antibiotics3%11 of 358 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2162024: 2233%

Drugs named by CMS: 7 in 2024, 6 in 2023.

See all prescribing by Dr. Schuetze

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Scott M. Schuetze offers telehealth to Medicare patients

Dr. Schuetze accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schuetze as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. Schuetze by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Scott M. Schuetze has 67 publications on record

Dmand AI links 67 papers to Dr. Schuetze, published from 2010 to 2025. 2015 was the busiest year, with 6. The most frequent topics are Sarcoma, Antineoplastic Combined Chemotherapy Protocols and Soft Tissue Neoplasms. Dr. Schuetze has published most often in J Natl Compr Canc Netw. Dr. Schuetze's most frequent co-authors are Rashmi Chugh, MD, Laurence H. Baker, DO and Kristen Nooshin Ganjoo, MD.

Papers67
Years published2010 to 2025

Dr. Schuetze's papers by year, 2015 to 2025

Topics Dr. Schuetze writes about most

  • Sarcoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Soft Tissue Neoplasms
  • Chemotherapy, Adjuvant
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Bone Neoplasms
  • Doxorubicin

Dr. Schuetze's most frequent co-authors

Recent publications by Dr. Schuetze

See all 67 publications and co-authors

See who Dr. Schuetze researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Schuetze works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Scott M. Schuetze has worked on 11 clinical trials

Dmand AI links Dr. Schuetze to 11 clinical trials, 8 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Gastrointestinal Stromal Tumors, Histiocytoma and Liposarcoma. National Cancer Institute (NCI) sponsors the most, 4. Open Payments lists research payments to Dr. Schuetze that name 1 trial.

Clinical trials with Dr. Schuetze by phase

  1. NonePhase 1: no trials
  2. 8Phase 2: 8 trials
  3. 1Phase 2/3: 1 trial
  4. 1Phase 3: 1 trial
  5. NonePhase 4: no trials

Conditions in Dr. Schuetze's trials

  • Gastrointestinal Stromal Tumors
  • Histiocytoma
  • Liposarcoma
  • Liposarcoma, Myxoid
  • Histiocytoma, Malignant Fibrous

Investigators on the most trials with Dr. Schuetze

Recent clinical trials with Dr. Schuetze

See all 11 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Scott M. Schuetze received $18,823 in industry payments from 2016 to 2025

CMS Open Payments shows 33 general payments to Dr. Schuetze from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Boehringer Ingelheim USA, Inc. paid the most, $8,241. It also lists 2 research payments totaling $1,236 from 2016 to 2025, naming 1 clinical trial.

General payments to Dr. Schuetze by program year, 2016 to 2025

General payments to Dr. Schuetze by kind, 2016 to 2025

$18.8Kin total
  • Consulting fees$10,74057%
  • Speaker and faculty fees$3,92121%
  • Honoraria$1,7559%
  • Travel and lodging$1,3447%
  • Other$1,0636%

Companies that paid Dr. Schuetze the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Schuetze

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Scott M. Schuetze graduated from Oregon Health Sciences University School of Medicine

Dr. Schuetze graduated from Oregon Health Sciences University School of Medicine in 1993.

  1. Medical schoolOregon Health Sciences University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Scott M. Schuetze's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Scott M. Schuetze

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Scott M. Schuetze's NPI number?

Dr. Scott M. Schuetze's NPI number is 1548346414. It was assigned on October 31, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Scott M. Schuetze?

Dr. Scott M. Schuetze is a medical oncologist in Ann Arbor, Michigan. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Scott M. Schuetze practice?

Dr. Schuetze practices at 1500 E Medical Center Dr, Ann Arbor, MI 48109. Dr. Schuetze's primary practice is University Hospital in Ann Arbor, Michigan.

What is Dr. Scott M. Schuetze's office phone number?

The practice phone on file for Dr. Schuetze is (734) 936-4000.

What is Dr. Scott M. Schuetze's medical license number?

Dr. Schuetze holds Michigan license 4301084113.

Which hospitals is Dr. Scott M. Schuetze affiliated with?

Dr. Schuetze is affiliated with University Hospital.

What medical group is Dr. Scott M. Schuetze part of?

Dr. Schuetze is linked to University of Michigan Health.

Does Dr. Scott M. Schuetze accept Medicare?

Yes. CMS data shows Dr. Schuetze billed Medicare for 209 services in 2024, and Dr. Schuetze accepts Medicare assignment.

Does Dr. Scott M. Schuetze offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Schuetze as offering telehealth services.

How many Medicare patients does Dr. Scott M. Schuetze see?

CMS counts 80 Medicare patients who saw Dr. Schuetze in 2024, with an average age of 70.

Show 7 more questionsShow fewer questions

What services does Dr. Scott M. Schuetze bill to Medicare?

In 2024, Dr. Schuetze's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and medicare service (G2211).

Where did Dr. Scott M. Schuetze go to medical school?

Dr. Schuetze graduated from Oregon Health Sciences University School of Medicine in 1993.

What drugs does Dr. Scott M. Schuetze prescribe most?

In 2024 Medicare Part D data, Dr. Schuetze's most prescribed drugs by claims were Imatinib Mesylate, Dexamethasone and Ondansetron HCl.

Has Dr. Scott M. Schuetze received payments from drug or device companies?

CMS Open Payments shows $18,823 in general payments to Dr. Schuetze from 7 companies from 2016 to 2025. The largest total came from Boehringer Ingelheim USA, Inc.

How long has Dr. Scott M. Schuetze been practicing?

Dr. Schuetze graduated from medical school in 1993, 33 years ago.

Does Dr. Scott M. Schuetze do research?

Dmand AI links 67 publications to Dr. Schuetze, published from 2010 to 2025. Dr. Schuetze has worked on 11 clinical trials.

Who does Dr. Scott M. Schuetze publish with?

Dr. Schuetze's most frequent co-authors are Rashmi Chugh, MD (25 shared papers), Laurence H. Baker, DO (15 shared papers) and Kristen Nooshin Ganjoo, MD (12 shared papers).

Selling to medical oncology practices?

See medical oncologists in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)